Longitudinal study of brain morphology in first episode schizophrenia

Biological Psychiatry

Volumn 49, Issue 6, 2001, Pages 487-499

  Lieberman, Jeffrey ^a   Chakos, Miranda ^a   Wu, Huwei ^b   Alvir, Jose ^b   Hoffman, Elaine ^d   Robinson, Delbert ^b   Bilder, Robert ^b,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b ZUCKER HILLSIDE HOSPITAL   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

First episode of psychosis; Hippocampus; MRI brain imaging; Neurodegeneration; Schizophrenia; Ventricles

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN VENTRICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; FEMALE; FOLLOW UP; HIPPOCAMPUS; HUMAN; HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORPHOLOGY; NEGATIVE SYNDROME; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; CAUDATE NUCLEUS; CEREBRAL VENTRICLES; FEMALE; FOLLOW-UP STUDIES; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; SCHIZOPHRENIA;

EID: 0035869532     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01067-8     Document Type: Article

References (58)

1. Computerized volume measurement of brain structure
2. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia
3. Advancing a neurodevelopmental origin for schizophrenia
4. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia
5. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia
6. Incidence and correlates of tardive dyskinesia in first episode of schizophrenia
7. Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine
8. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs
9. Striatal enlargement in rats chronically treated with neuroleptic
10. Change in basal ganglia volume over 2 years in patients with schizophrenia: Typical versus atypical neuroleptics
11. The course of schizophrenia: Evidence for dynamic change processes
12. Ventricular enlargement in poor-outcome schizophrenia
13. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients
14. Regional brain volume change over the life-time course of schizophrenia
15. Left ventricular enlargement associated with diagnostic outcome of schizophreniform disorder
16. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia
17. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: Preliminary findings
18. A diagnostic interview: The schedule for affective disorders and schizophrenia
19. An open trial of clozapine in eleven adolescents with childhood-onset schizophrenia
20. Etiologic heterogeneity of the psychoses: Is there a dopamine psychosis?
21. A follow-up magnetic resonance imaging study in schizophrenia
22. The course of schizophrenia: Evidence for dynamic change processes
23. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia
24. Cerebral ventricular enlargement in schizophreniform disorder does not progress: A seven year follow-up study
25. Cerebral ventricular size and cognitive impairment in chronic schizophrenia
26. Ventricle-to-brain ratio in schizophrenia: A controlled follow-up study
27. Changes in caudate volume with neuroleptic treatment
28. Frontotemporal dementia and Alzheimer disease: Evaluation of cortical atrophy with automated hemispheric surface display generated with MR images
29. Heterogeneity of the psychoses: Is there a neurodegenerative psychosis?
30. Childhood-onset psychotic disorders: Magnetic resonance imaging of volumetric differences in brain structure
31. MRI changes during water loading in patients with polydipsia and intermittent hyponatremia
32. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective
33. Psychobiologic correlates of treatment response in schizophrenia
34. Prospective study of psychobiology in first episode schizophrenia at Hillside Hospital: Design, methodology and summary of findings
35. Qualitative assessment of brain morphology in acute and chronic schizophrenia
36. Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates
37. Time course and biological correlates of treatment response in first episode schizophrenia
38. Dopaminergic mechanisms of idiopathic and drug induced psychosis
39. Duration of psychosis and outcome in first-episode schizophrenia
40. MRI anatomy of schizophrenia
41. A selective review of recent North American long-term follow-up studies of schizophrenia
42. Magnetic resonance imaging in schizophrenia: Relationship with clinical measures
43. Progression of cerebroventricular alignment and the subtyping of schizophrenia
44. Childhood-onset schizophrenia: Progressive ventricular change during adolescence
45. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum
46. Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder
47. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder
48. Alzheimer disease: Measuring loss of cerebral gray matter with MR imaging
49. Increased volume and density in primate prefrontal cortex associated with chronic antipsychotic drug exposure
50. A review of magnetic resonance imaging studies of brain abnormalities in schizophrenia brain imaging in clinical psychiatry
51. A rating scale for extrapyramidal side effects
52. Stability of cerebral ventricular size from the appearance of the first psychotic symptoms to the later diagnosis of schizophrenia
53. Cerebellar morphology as a predictor of symptom and psychosocial outcome in schizophrenia
54. Implications of normal brain development for the pathogenesis of schizophrenia
55. Early intervention with neuroleptics may decrease the long-term morbidity of schizophrenia